Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campbell, M. Articles by Speert, D. P. Search for Related Content PubMed PubMed Citation Articles by Campbell, M. Articles by Speert, D. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2000, p. 4614-4615, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evaluation of Random Amplified Polymorphic DNA Typing of Pseudomonas aeruginosa

Maureen Campbell, Eshwar Mahenthiralingam, and David P. Speert^*

Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia, and Children's and Women's Health Centre of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada

Received 7 March 2000/Returned for modification 18 August 2000/Accepted 21 September 2000

	ABSTRACT

Top Abstract Text References

A method for distinguishing among Pseudomonas aeruginosa strains using random amplified polymorphic DNA (RAPD) typing was evaluated for reproducibility and discriminatory power. A total of 200 isolates, blinded in triplicate, were evaluated by RAPD. All 600 samples were typeable; 197 of 200 isolates gave identical results on all three occasions, and 131 distinct RAPD types were identified.

	TEXT

Top Abstract Text References

Pseudomonas aeruginosa is the predominant respiratory pathogen in patients with cystic fibrosis (CF) (11), but its means of acquisition and the risk of patient-to-patient spread remain poorly understood. To enable epidemiological studies of sequential isolates from CF patients, a reliable and simple method of fingerprinting is necessary. This study describes the evaluation of a method for typing P. aeruginosa using random amplified polymorphic DNA (RAPD) fingerprinting.

Bacterial isolates. A total of 200 isolates of P. aeruginosa, obtained from a previous study (4), were frozen in triplicate (600 samples), each with a unique blinded code number. The sources included 150 isolates from 109 patients with CF (from five geographically distinct locations), 17 International Antigenic Typing System (IATS) type strains, 23 isolates from 22 non-CF patients, and 10 isolates from the environment (river and vegetables).

RAPD typing. Samples were grown from frozen stock on Columbia agar with 5% sheep's blood (Prepared Media Laboratories, Richmond, British Columbia, Canada). Pure cultures were prepared for RAPD analysis as previously described (7), and extracted DNA was amplified using sequence 272 (5'-AGCGGGCCAA-3') and sequence 208 (5'-ACGGCCGACC-3'). RAPD patterns were analyzed by an observer who was blind to isolate identity; comparisons among and between samples were performed both visually and using Molecular Analyst Fingerprinting (MAF) software (Bio-Rad Laboratories) with Pearson product-moment correlation coefficient, unweighted pair group method using arithmetic averages, and global optimization. Banding patterns with a similarity index of >75% by MAF or which appeared similar visually were run again, side by side on the same gel, to confirm the identity. Two or more samples with the same banding pattern were assigned a number indicating a single RAPD type. Those with no more than one major band or three minor band differences were thought to be possibly related and subjected to further analysis by pulsed-field gel electrophoresis (PFGE) (6).

Typeability and reproducibility. Of 200 isolates, 197 yielded reproducible fingerprints from all three samples by RAPD analysis (i.e., the same RAPD type) (Table 1). The remaining three isolates yielded reproducible results in two of three samples. A total of 150 isolates from 109 CF patients from six clinics were analyzed. Multiple morphotypes (two to four) were evaluated from each of 32 patients; in all cases, the different samples from each patient yielded identical RAPD patterns.

View this table: [in this window] [in a new window]   TABLE 1.   Typeability and reproducibility of RAPD analysis of P. aeruginosa isolatesa

RAPD types. There were a total of 131 RAPD types identified among the 600 samples (Table 2). Of 38 types, each contained more than one isolate, 15 of which were multiple isolates from individual patients. A total of 108 RAPD types were unique to a single patient or source (Table 2), including 66 types unique to CF patients (80 of 150 isolates) and 16 types unique to non-CF patients. All 10 environmental and 16 of 17 IATS isolates yielded unique RAPD types. In total, 23 RAPD types were shared by multiple patients or sources (Table 2), including 4 types by sibling pairs, 14 types by unrelated CF patients, 3 types by CF with non-CF patients, 1 type by unrelated non-CF patients, and 1 type by a non-CF patient with an IATS strain.

View this table: [in this window] [in a new window]   TABLE 2.   Distribution of unique and shared RAPD types among different sources of P. aeruginosa

The epidemiology of P. aeruginosa in CF patients is controversial. Some studies have suggested patient-to-patient spread (1-3, 10), whereas others have failed to find such evidence (5, 8, 12, 13). It is important to clarify the epidemiology of P. aeruginosa in CF in order to rationally design infection control policies. A previous study (4) indicated that restriction fragment length polymorphism analysis using a probe upstream from the gene for exotoxin A proved to have the greatest discriminatory power. This approach was significantly superior to phenotypic methods, yielding the greatest number of distinct patterns among isolates that were reproducibly typed (54 unique types among 145 isolates). This method indicated that the changes in colonial morphology of sequential isolates from a patient do not represent replacement by a new strain but rather phenotypic plasticity (7, 9). Before evaluation of a large number of patient isolates from Canadian clinics to further clarify the epidemiology of infection in CF, it was necessary to first determine if RAPD typing (a simple gene-based technique) could give reproducible and discriminatory results.

The study employed the same 600 samples from the previous investigation (4) to evaluate RAPD typing and found that it had a high degree of reproducibility, with 98.5% yielding the same banding patterns for each triplicate. Epidemiologically related isolates, such as multiple isolates from individual patients and those from each of five sibling pairs, were appropriately "read" as identical by RAPD. Isolates that were epidemiologically unrelated, such as those from the environmental and the IATS type strains, each had a unique RAPD pattern.

This method was highly reproducible and was able to differentiate apparently unrelated strains. RAPD typing is a robust, simple, and highly reproducible method that should be useful in clarifying the epidemiology of P. aeruginosa in patients with CF. RAPD typing is best suited to situations in which a large number of isolates are to be evaluated. Results from RAPD analysis can be used in conjunction with the more cumbersome PFGE method to resolve and confirm the difference or identity among smaller numbers of isolates when an ambiguous result is obtained with RAPD.

	ACKNOWLEDGMENTS

This work was supported by a grant to D.P.S. from the Canadian Cystic Fibrosis Foundation.

We thank Spencer Matheson, Nicole Glenham, and Gary Probe for excellent technical support.

	FOOTNOTES

^* Corresponding author. Mailing address: B.C. Research, 950 West 28th Ave., Rm. 377, Vancouver, BC V5Z 4H4 Canada. Phone: 604-875-2438. Fax: 604-875-2226. E-mail: speert{at}interchange.ubc.ca.

Present address: Cardiff School of Biosciences, Cardiff University, Cardiff, Wales C17 3T1, United Kingdom.

	REFERENCES

Top Abstract Text References

1.	Cheng, C. K., R. L. Smyth, R. Govan, C. Doherty, C. Winstanley, N. Denning, D. P. Heaf, and H. van Saene. 1996. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348:1596-1597.
2.	Farrell, P. M., G. Shen, M. Splaingard, C. E. Colby, A. Laxova, M. R. Kosorok, M. J. Rock, and E. H. Mischler. 1997. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 100:E2.
3.	Høiby, N., and K. Rosendal. 1980. Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. Acta Pathol. Microbiol. Scand. B 88:125-131[Medline].
4.	International P. aeruginosa Typing Study Group. 1994. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Infect. Dis. 169:134-142[Medline].
5.	Kelly, N. M., M. X. Fitzgerald, E. Tempany, C. O'Boyle, F. R. Falkiner, and C. T. Keane. 1982. Does Pseudomonas cross-infection occur between cystic fibrosis patients? Lancet ii:688-690.
6.	Lightfoot, J., and J. S. Lam. 1993. Chromosomal mapping, expression and synthesis of lipopolysaccharide in Pseudomonas aeruginosa: a role for guanosine diphospho (GDP)-D-mannose. Mol. Microbiol. 8:771-782[CrossRef][Medline].
7.	Mahenthiralingam, E., M. E. Campbell, J. Foster, J. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135[Abstract].
8.	Ogle, J. W., J. M. Janda, D. E. Woods, and M. L. Vasil. 1987. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J. Infect. Dis. 155:119-126[Medline].
9.	Pasloske, B. L., A. M. Joffe, Q. Sun, K. Volpel, W. Paranchych, W, F. Eftekhar, and D. P. Speert. 1988. Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences. Infect. Immun. 56:665-672[Abstract/Free Full Text].
10.	Pedersen, S. S., C. Koch, N. Høiby, and K. Rosendal. 1986. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother. 17:505-516[Abstract/Free Full Text].
11.	Speert, D. P. 1994. Pseudomonas aeruginosa infections in patients with cystic fibrosis, p. 183-234. In A. L. Baltch, and R. P. Smith (ed.), Pseudomonas aeruginosa infections and treatment. Marcel Decker, New York, N.Y.
12.	Speert, D. P., and M. E. Campbell. 1987. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Hosp. Infect. 9:11-21[CrossRef][Medline].
13.	Speert, D. P., D. Lawton, and S. Damm. 1982. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J. Pediatr. 101:227-229[CrossRef][Medline].

---

Journal of Clinical Microbiology, December 2000, p. 4614-4615, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

This article has been cited by other articles:

• Lin, H.-H., Huang, S.-p., Teng, H.-C., Ji, D.-D., Chen, Y.-S., Chen, Y.-L. (2006). Presence of the exoU Gene of Pseudomonas aeruginosa Is Correlated with Cytotoxicity in MDCK Cells but Not with Colonization in BALB/c Mice. J. Clin. Microbiol. 44: 4596-4597 [Abstract] [Full Text]  
• Nishio, H., Komatsu, M., Shibata, N., Shimakawa, K., Sueyoshi, N., Ura, T., Satoh, K., Toyokawa, M., Nakamura, T., Wada, Y., Orita, T., Kofuku, T., Yamasaki, K., Sakamoto, M., Kinoshita, S., Aihara, M., Arakawa, Y. (2004). Metallo-{beta}-Lactamase-Producing Gram-Negative Bacilli: Laboratory-Based Surveillance in Cooperation with 13 Clinical Laboratories in the Kinki Region of Japan. J. Clin. Microbiol. 42: 5256-5263 [Abstract] [Full Text]  
• Giakkoupi, P., Petrikkos, G., Tzouvelekis, L. S., Tsonas, S., Legakis, N. J., Vatopoulos, A. C. (2003). Spread of Integron-Associated VIM-Type Metallo-{beta}-Lactamase Genes among Imipenem-Nonsusceptible Pseudomonas aeruginosa Strains in Greek Hospitals. J. Clin. Microbiol. 41: 822-825 [Abstract] [Full Text]  
• Speert, D. P., Campbell, M. E., Henry, D. A., Milner, R., Taha, F., Gravelle, A., Davidson, A. G. F., Wong, L. T. K., Mahenthiralingam, E. (2002). Epidemiology of Pseudomonas aeruginosa in Cystic Fibrosis in British Columbia, Canada. Am. J. Respir. Crit. Care Med. 166: 988-993 [Abstract] [Full Text]  
• Poirel, L., Weldhagen, G. F., De Champs, C., Nordmann, P. (2002). A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum {beta}-lactamase GES-2 in South Africa. J Antimicrob Chemother 49: 561-565 [Abstract] [Full Text]  
• Dautle, M. P., Ulrich, R. L., Hughes, T. A. (2002). Typing and Subtyping of 83 Clinical Isolates Purified from Surgically Implanted Silicone Feeding Tubes by Random Amplified Polymorphic DNA Amplification. J. Clin. Microbiol. 40: 414-421 [Abstract] [Full Text]  
• Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., Hauser, A. R. (2001). Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147: 2659-2669 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Campbell, M. Articles by Speert, D. P. Search for Related Content PubMed PubMed Citation Articles by Campbell, M. Articles by Speert, D. P.